Human Umbilical Cord Mesenchymal Stem Cell(UC-MSC) Therapy(Tongji Hospital)

N/A

Report date: 2023/01/12 15:41:01

Base Information

Drug NameHuman Umbilical Cord Mesenchymal Stem Cell(UC-MSC) Therapy(Tongji Hospital)
Drug Alias NameHuman Umbilical Cord Mesenchymal Stem Cell(UC-MSC)UC-MSChUC-MSCUC-MSChUC-MSC
ClassificationCell and gene therapy > Cell therapy > Source of cells > Umbilical cord-derivedCell and gene therapy > Cell therapy > Stem cell therapy > Mesenchymal stem cells therapy
Mechanisms of ActionStem cell replacements
TargetsNot applicable
Therapy Area/IndicationsRenal Insufficiency, ChronicErectile Dysfunction
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaPhase 2 Clinical
Originator CompaniesTongji Hospital
China Registration ClassN/A

Develop Information

Active CompaniesTongji HospitalIndonesia University
Inactive CompaniesN/A
Active IndicationsRenal Insufficiency, ChronicErectile Dysfunction
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A